Modified Triple Chemotherapy

[1]  J. Lurain,et al.  Treatment of High-Risk Gestational Trophoblastic Disease With Methotrexate, Actinomycin D, and Cyclophosphamide Chemotherapy , 1985, Obstetrics and gynecology.

[2]  D. Gershenson,et al.  High-Risk Metastatic Gestational Trophoblastic Disease , 1985, Obstetrics and gynecology.

[3]  L. Twiggs,et al.  Preliminary report of toxicity in a randomized comparison of methotrexate, actinomycin D, and chlorambucil (MAC) versus modified Bagshawe regimen in “poor prognosis” gestational trophoblastic disease , 1985 .

[4]  H. Ma,et al.  Use of oral VP16-213 as primary chemotherapeutic agent in treatment of gestational trophoblastic disease. , 1984, American journal of obstetrics and gynecology.

[5]  Bagshawe Kd.  Treatment of high-risk choriocarcinoma. , 1984 .

[6]  R. Berkowitz,et al.  Modified triple chemotherapy in the management of high-risk metastatic gestational trophoblastic tumors. , 1984, Gynecologic oncology.

[7]  R. Berkowitz,et al.  Pelvic ultrasonography and the management of gestational trophoblastic disease. , 1983, Gynecologic oncology.

[8]  R. Berkowitz,et al.  Methotrexate with citrovorum factor rescue as primary therapy for gestational trophoblastic disease , 1982, Cancer.

[9]  J. Lurain,et al.  Gestational Trophoblastic Disease: Treatment Results at the Brewer Trophoblastic Disease Center , 1982, Obstetrics and gynecology.

[10]  L. Clayton,et al.  Chemotherapy with the modified Bagshawe protocol for poor prognosis metastatic trophoblastic disease. , 1982, Obstetrics and gynecology.

[11]  R. Berkowitz,et al.  Gestational Trophoblastic Neoplasms: Clinical Principles of Diagnosis and Management , 1982 .

[12]  R. Berkowitz,et al.  Pretreatment Curettage—A Predictor of Chemotherapy Response in Gestational Trophoblastic Neoplasia , 1980, Gynecologic oncology.

[13]  R. Berkowitz,et al.  Laparoscopy in the management of gestational trophoblastic neoplasms. , 1980, Journal of reproductive medicine.

[14]  Hammond Cb,et al.  Treatment of metastatic trophoblastic disease with poor prognosis. , 1980 .

[15]  J. Schlaerth,et al.  Sustained remission of choriocarcinoma with cis-platinum, vinblastine, and bleomycin after failure of conventional combination drug therapy. , 1980, American journal of obstetrics and gynecology.

[16]  J. Weed,et al.  The role of operation in the current therapy of gestational trophoblastic disease. , 1980, American journal of obstetrics and gynecology.

[17]  E. Newlands,et al.  Anti-tumour activity of the epipodophyllin derivative VP16-213 (etoposide: NSC-141540) in gestational choriocarcinoma. , 1980, European journal of cancer.

[18]  R. Berkowitz,et al.  Methotrexate with citrovorum factor rescue reduced chemotherapy toxicity in the management of gestational trophoblastic neoplasms , 1980, Cancer.

[19]  H. Ma,et al.  Clinical trial of bleomycin in the treatment of gestational trophoblastic disease. , 1979, Gynecologic oncology.

[20]  E. Newlands,et al.  Activity of high-dose cis-platinum (NCI 119875) in combination with vincristine and methotrexate in drug-resistant gestational choriocarcinoma. A report of 17 cases. , 1979, British Journal of Cancer.

[21]  E. Surwit,et al.  A new combination chemotherapy for resistant trophoblastic disease. , 1979, Gynecologic oncology.

[22]  E. Surwit,et al.  Choriocarcinoma Following Term Pregnancy , 1979, Obstetrics and gynecology.

[23]  K. Bagshawe.  Risk and prognostic factors in trophoblastic neoplasia , 1976, Cancer.

[24]  K. Bagshawe,et al.  Immunodiagnosis and monitoring of gonadotrophin‐producing metastases in the central nervous system , 1976, Cancer.

[25]  J. Lewis,et al.  Current status of treatment of gestational trophoblastic disease , 1976, Cancer.

[26]  W. Creasman,et al.  Treatment of metastatic trophoblastic disease: good and poor prognosis. , 1973, American journal of obstetrics and gynecology.

[27]  G T Ross,et al.  A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormone. , 1972, American journal of obstetrics and gynecology.

[28]  D. Goldstein,et al.  Actinomycin D As Initial Therapy Of Gestational Trophoblastic Disease: A Reevaluation , 1972, Obstetrics and gynecology.

[29]  K. Brace.  The Role of Irradiation in the Treatment of Metastatic Trophoblastic Disease , 1968 .

[30]  G. Ross,et al.  SEQUENTIAL USE OF METHOTREXATE AND ACTINOMYCIN D IN THE TREATMENT OF METASTATIC CHORIOCARCINOMA AND RELATED TROPHOBLASTIC DISEASES IN WOMEN. , 1965, American journal of obstetrics and gynecology.

[31]  C. E. Wilde,et al.  INFUSION THERAPY FOR PELVIC TROPHOBLASTIC TUMOURS , 1964, The Journal of obstetrics and gynaecology of the British Commonwealth.

[32]  G. Ross,et al.  Actinomycin D in the treatment of methotrexate-resistant trophoblastic disease in women. , 1962, Cancer research.

[33]  J. Lewis,et al.  Five year's experience with the chemotherapy of metastatic choriocarcinoma and related trophoblastic tumors in women. , 1961, American journal of obstetrics and gynecology.

[34]  W. Whitmore,et al.  Effects of combined drug therapy on metastatic cancer of the testis. , 1960, JAMA.

[35]  M. Lipsett,et al.  Effect of Vincaleukoblastine on metastatic choriocarcinoma and related trophoblastic tumors in women. , 1960, Cancer research.

[36]  R. Hertz,et al.  Effect of Methotrexate Therapy upon Choriocarcinoma and Chorioadenoma , 1956, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[37]  R. Berkowitz,et al.  Choriocarcinoma following term gestation. , 1984, Gynecologic oncology.

[38]  Hammond Cb,et al.  Diagnosis and treatment of trophoblastic disease. A report from the Southeastern Regional Center. , 1970 .